Conjupro Biotherapeutics is a pharmaceutical company that specializes in clinical research and drug development for various diseases.
Conjupro Biotherapeutics has raised $9.3M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in September 2023.
Conjupro Biotherapeutics is headquartered in Princeton, United States.
Conjupro Biotherapeutics is a pharmaceutical company that specializes in clinical research and drug development for various diseases.
Conjupro Biotherapeutics is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Conjupro Biotherapeutics — Funding & Investors." VCBacked, September 12, 2023, https://www.vcbacked.co/company/conjupro-biotherapeutics. Accessed August 13, 2026.
VCBacked. (2023). Conjupro Biotherapeutics — Funding & Investors. Retrieved August 13, 2026, from https://www.vcbacked.co/company/conjupro-biotherapeutics
{{cite web |title=Conjupro Biotherapeutics — Funding & Investors |url=https://www.vcbacked.co/company/conjupro-biotherapeutics |website=VCBacked |access-date=August 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated